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Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a rare genetic disease, with variable penetrance 26 
[1]. First described in 1736 by Giovanni Maria Lancisi in “De Motu Cordis et Aneurysmatibus” [2], it was 27 
initially thought to involve primarily the right ventricle (RV), with partial or total absence of the RV 28 
musculature and fibro-fatty replacement [3-4], but recent evidence showed that in up to 70% of cases there is 29 
also left ventricular (LV) involvement [5-7]. Clinical symptoms are often heterogeneous and non-specific, 30 
including palpitations, syncope and atypical chest pain, hence representing a diagnostic challenge. ARVC can 31 
lead to biventricular heart failure and sudden cardiac death (SCD), which represents the first manifestation of 32 
the disease in up to 20% of cases [8].  Implantable Cardioverter Defibrillator (ICD) decreases the risk of SCD, 33 
so a correct diagnosis is crucial. The diagnosis of ARVC is based on the 2010 Task Force Criteria (TFC) [9], 34 
which recommend a multi-parametric approach that takes into account echocardiographic, electrocardiographic 35 
and histologic abnormalities, documented ventricular arrhythmia and family history. Imaging criteria for ARVC 36 
subtend potential diagnostic pitfalls of which the clinician needs to be aware: normal variants mischaracterized 37 
as ARVC, such as chest wall deformity and non-ARVC fatty infiltration (obesity, post-myocardial infarction), 38 
and pathologic conditions mimicking ARVC, such as myocarditis, sarcoidosis and pre-tricuspid shunts, which 39 
are commonly referred to as ARVC mimics [10]. Cardiovascular Magnetic Resonance (CMR) as part of the 40 
2010 TFC is increasingly used in clinical practice in patients with suspected ARVC in the context of a multi-41 
modality imaging assessment. The aim of our study was to assess the diagnostic role of CMR in patients 42 
referred for suspected ARVC and its ability to identify ARVC mimics, and to explore its additional clinical 43 
impact.  44 
 45 
Materials and methods: 46 
We retrospectively analysed the CMR registry data from the year 2014 (January to December) of a UK tertiary 47 
centre, to identify consecutive patients referred for suspected ARVC. Clinical, ECG and echocardiographic data 48 
were collected from clinical records. CMR was performed on a 1.5 T scanner (Magnetom Avanto, Siemens 49 
Medical Solutions, Enlargen, Germany) and all patients underwent a CMR protocol including the left 50 
ventricular (LV) and right ventricular (RV) anatomy, cine and late gadolinium enhancement (LGE) images. 51 
Cine images were performed using a steady-state free-precession sequence in the 4-chamber, 3-chamber and 2-52 
chamber long-axis view, followed by a stack of short-axis slice from base to apex; typical image parameters 53 
 3 
were TR 38 ms, TE 1.07 ms, flip angle 80°, bandwidth 930 Hz/Px, voxel size 2.0x2.0.8.0mm, slice thickness 8 54 
mm, inter-slice gap 0 mm. Additional RVOT cine images were obtained, followed by a stack of axial views 55 
(slice thickness 5mm, inter-slice gap 5mm) through the RVOT from the pulmonary valve to the RV 56 
diaphragmatic wall. LGE images were obtained 15-20 minutes after intravenous administration of 0.1 mmol/Kg 57 
of gadobutrol (Gadovist 1.0 mmol/ml, Bayer-Schering, Berlin, Germany) in identical planes to the long- and 58 
short-axis cine images, using an inversion recovery segmented gradient echo sequence. Typical image 59 
parameters were TR 700 ms, TE 3.15 ms, flip angle 25°, slice thickness 8.0 mm, interslice gap 0 mm, bandwidth 60 
140 Hx/Px, voxel size 2.0x1.5x8.0 mm. The inversion time was progressively optimized to null normal 61 
myocardium (typical values, 250–350 ms). Each slice was obtained during a breath-hold of 10–15 s depending 62 
on the patient’s heart rate. According to 2010 Task Force Criteria [9], CMR criteria were defined as major in the 63 
presence of regional RV akinesia/dyskinesia/dyssynchronous contraction, associated with ratio of right 64 
ventricular end-diastolic volume (RVEDV) to body surface area (BSA) ≥110 ml/m2 (male) or ≥100 ml/m2 65 
(female), or RV ejection fraction (RVEF) ≤40%; minor criterion was defined as the presence of regional RV 66 
akinesia/dyskinesia/dyssynchronous contraction, associated with ratio of RV end-diastolic volume (RVEDV) to 67 
body surface area (BSA) 100-109 ml/m2 (male) or 90-99 ml/m2 (female), or RV ejection fraction (RVEF) 40%-68 
45% . Body surface area was calculated using the Du Bois method. The study was reviewed by the local 69 
Institutional Research and Innovation Department and in view of its retrospective design a formal ethical 70 
approval was waived. 71 
 72 
Statistical analysis: 73 
Continuous and categorical variables were expressed as mean±SD and n (%), respectively. Continuous data 74 
were compared by using the 2-tailed unpaired t test or by using the Mann-Whitney U test. Categorical variables 75 
were compared by using the chi-square test or Fisher exact test, as appropriate. A p-value of <0.05 was 76 
considered statistically significant; a Bonferroni-corrected p-value was used for comparison > 2 groups. 77 
Comparisons between more than two groups were assessed using the Kruskall-Wallis test, using Dunn’s test for 78 





Out of 2,481 scans performed in our CMR centre between Jan-Dec 2014, we identified 124 patients (5%) (56% 83 
male, mean age 41±16 years, age range 17-78 years) referred for suspected ARVC. Patients were referred with 84 
suspected ARVC/D on the basis of symptoms, family history of ARVC and/or SCD, abnormal ECG or 85 
abnormal transthoracic echocardiogram (TTE). Eighty-five patients (69%) were symptomatic: history of 86 
palpitations/arrhythmias was reported in 53 patients (43%), syncope with no documented arrhythmia in 26 87 
(21%) and both history of arrhythmia and syncope in 6 patients (5%), while thirty-nine patients (31%) were 88 
asymptomatic, with an abnormal ECG and/or TTE found incidentally during school or competitive sport pre-89 
participation screening or pre-operatively. ECG data were available in 65 patients (52%): 53/65 patients (82%) 90 
had abnormal ECG, most commonly T-wave inversion in leads V1-V3. Echocardiographic data were available 91 
in 96 patients (77%): 26/96 patients (27%) had evidence of abnormal RV on echocardiogram. Family history of 92 
SCD was reported in 16 patients (13%), 5 patients (4%) had family history of ARVC and one patient (1%) had 93 
family history of both SCD and ARVC (table 1).  94 
 95 
CMR Findings: 96 
Biventricular volumes and function were overall preserved: mean LV ejection fraction (LVEF) was 61±8%, 97 
mean LV end-diastolic volume (LVEDV) was 83±24 ml/m2 and mean LV end-systolic volume (LVESV) was 98 
34±19 ml/m2; mean RV ejection fraction (RVEF) was 58±8%, mean RVEDV 84±23 ml/m2 and mean RV end-99 
systolic volume (RVESV) was 36±15 ml/m2. Thirteen patients (10%) had evidence of LGE. Based on CMR 100 
findings, a pathologic substrate was found in 36 patients (29%): ischemic heart disease (IHD) was found in 5 101 
patients (4%) and non-ischemic heart disease in 10 (8%); 5 patients (4%) met CMR imaging criteria for ARVC 102 
(Figure 1A, B, C and D), of which one had findings consistent with ALVC, and sixteen patients (13%) were 103 
ARVC mimics. A structurally normal heart was found in 82 patients (66%) and non-specific findings (mild non-104 
specific regional wall motion abnormalities) in 6 (5%). CMR findings are listed in Table 2. Echocardiographic 105 
data were available in 96 patients (77%). TTE and CMR findings agreed in 49 patients (51%); CMR provided 106 
an entirely new diagnosis in 22 patients (22%) and found a structurally normal heart in 20 patients (21%) who 107 
had abnormal findings on TTE. One patient (1%) was identified as ARVC mimics on TTE, as compared to 12 108 
(13%) identified on CMR (p=0.01).  109 
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ARVC mimics: 110 
Sixteen patients (13%) were found to have ARVC mimics on CMR. Six patients had normal variant 111 
mischaracterized as ARVC: one patient had a pectus excavatum (Figure 2A and B) and five had findings 112 
consistent with athlete’s heart. Ten patients had pathologic conditions mimicking ARVC: cardiac sarcoidosis 113 
(n=1), myocarditis (n=1), RV myocardial infarction (n=1), partial congenital absence of pericardium (n=1)  114 
(Figure 2C and D); 3 patients were diagnosed with left ventricular non compaction (LVNC) and 3 with pre-115 
tricuspid left to right shunting (2 atrio-ventricular septal defect, ASD, and 1 partial anomalous venous return) 116 
(Figure 3). There was no significant difference in clinical, ECG and TTE characteristics between patients with 117 
structurally normal hearts on CMR and those with ARVC and ARVC mimics, and between ARVC and ARVC 118 
mimics and the remaining population (Table 1). RVEDV and RV stroke volume (SV) were significantly higher 119 
in patients with ARVC (RVEDV p=0.013, RVSV p=0.013) and ARVC mimics (RVEDV p=0.007, RVSV 120 
p=0.012), as compared to those with structurally normal hearts. There was no significant difference in RV 121 
volumes and function in patients with ARVC and ARVC mimics, while LVESV was significantly larger in 122 
patients with ARVC. When comparing patients with ARVC and ARVC mimics (n=21) and the remaining 123 
population (n=103), there was no significant difference in clinical, ECG and TTE characteristics while 124 
biventricular volumes and RV stroke volume were significantly higher in patients with ARVC and ARVC 125 
mimics (RVEDV 79 vs 103 ml/m2, p=0.001; RVESV34 vs 47 ml/m2, p=0.018, RVSV 46 vs 56, p=0.001)(Tabel 126 
2). 127 
Discussion: 128 
Arrhythmogenic right ventricular cardiomyopathy is a rare disease, with variable penetrance and prognosis. 129 
Given the implications of such a diagnosis, the 2010 Task Force Criteria (TFC) recommended a multi-130 
parametric approach, comprehensive of imaging findings, family history, arrhythmias, ECG and histologic 131 
abnormalities [9]. The symptoms of the disease are non-specific (chest pain, palpitations) and overlap with other 132 
cardiomyopathies, thus not being helpful for a definite diagnosis [3,4,7,8]. It is well established that the 133 
diagnosis of ARVC cannot rely on imaging findings alone, as imaging is subject to diagnostic pitfalls, such as 134 
normal variants mischaracterized for ARVC (i.e. athlete’s heart) or pathologic conditions mimicking it [10]. 135 
Bomma et al. [11] showed that less than 30% of patients referred for ARVC actually met the TFC after a 136 
comprehensive clinical, invasive and non-invasive re-assessment. The advent of CMR offered a new insight into 137 
ARVC [12-18]: due to its superior spatial resolution, unique tissue characterization, increased contrast between 138 
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blood pool and endomyocardium and multi-planarity, CMR is considered the gold standard for the assessment 139 
of RV volumes and function. The implementation of the new TFC led to a significant reduction in the number of 140 
patients confirmed with the diagnosis: Sen-Chowdhry reported an excellent sensitivity but low specificity (29%) 141 
of CMR in relation to the TFC  [19]. Similar findings were confirmed by Vermes et al. [20,21], which showed a 142 
reduction in the prevalence of major and minor CMR criteria after the revised TFC. We found that only 5/124 143 
patients (4%) referred for suspected ARVC actually met the TFC, in keeping with findings from Quarta et al. 144 
[22] in a similar cohort. Normal and pathologic conditions mimicking ARVC make the diagnosis even more 145 
challenging. Chest wall deformity and non-ARVC related fatty infiltration (obesity, lipomatous metaplasia post-146 
myocardial infarction) could be misinterpreted as ARVC. Moreover, increased RV volumes in athlete’s heart or 147 
pre-tricuspid shunting often lead to misdiagnosis [24-29]. In our study we observed that 16/124 patients (13%) 148 
were found to have ARVC mimics, which were mainly represented by pathologic conditions rather than normal 149 
variants mimicking the disease, leading to important clinical implications. In our cohort, the prevalence of 150 
ARVC mimics was slightly higher compared with those previously reported in literature: Quarta et al. [22] 151 
reported a 5% prevalence of ARVC mimics among patients referred to CMR for suspected ARVC, with similar 152 
findings confirmed by Ting et al. [23], which showed a 4.4% prevalence of ARVC mimics. As CMR is part of 153 
the multi-modality assessment in patients with suspected ARVC, it is increasingly used in clinical practice, 154 
especially due to the potential clinical and prognostic implications that such a diagnosis would carry, and 155 
sometimes it is performed to definitely rule out ARVC also in cases where pre-test likelihood is low; we think 156 
this might at least in part explain the higher prevalence of ARVC mimics in our cohort. We also assessed the 157 
ability of TTE to identify ARVC mimics, and found that CMR was significantly superior (13% by CMR vs 1% 158 
by TTE, p=0.01). Although RV volumes were bigger in patients with ARVC and ARVC mimics, as compared 159 
to the remaining population, the lack of difference among clinical, ECG, TTE and CMR characteristics between 160 
ARVC and ARVC mimics, makes it challenging to identify ARVC mimics in the early differential diagnosis.  161 
Interestingly, we also found that 82/124 patients (66%) with suspected ARVC based on clinical assessment 162 
showed a structurally normal heart on CMR. Our study confirms and extends previous findings and highlights 163 
the limitations of the TFC that do not consider the occurrence of ARVC mimics. Tissue characterization by 164 
CMR, including LGE, might help in the differential diagnosis, however, to date, tissue characterization is 165 
currently not included among the TFC. The main limitation of our study is the retrospective design; moreover 166 
neither endomyocardial biopsy (given its little access in our Centre) nor genetic testing was available in our 167 
 7 
cohort. As ARVC is a rare disease, prospective multicentre studies are needed to confirm and expand our 168 
findings, aiming at improving the generalizability of our results.  169 
 170 
Conclusion: 171 
Out of 2,481 scans performed in our centre over a year, 124 (5%) were performed for suspected ARVC. Based 172 
on CMR findings, a pathologic substrate was found in 29% of patients and a structurally normal heart in 66%. 173 
ARVC imaging criteria were met in only 4% of patients, while 13% of patients showed findings consistent with 174 
ARVC mimics. CMR showed to be superior to TTE in the identification of ARVC mimics (13% vs 1%, p=0.01) 175 
and, overall, provided a change in diagnosis in 22% of patients. Accurate identification of the underlying 176 
pathology in patients with suspected ARVC is pivotal given the impact on clinical management and prognosis. 177 
Our study shows the incremental role of CMR in the identification of ARVC mimics, over and above TTE.  178 
 179 
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Figures captions 269 
Figure 1. Right and left-dominant arrhythmogenic cardiomyopathy.  270 
Top panel. Diastolic (A) and systolic (B) four chamber view showing dilated right ventricle with bulging of the 271 
free wall (solid arrows) in a patient meeting one major CMR criterion for ARVC. Bottom panel. Mid-cavity 272 
short axis cine sequence (C) with evidence of right ventricular free wall late gadolinium enhancement (LGE) (D, 273 
white arrow) and extensive LGE of the interventricular septum (C and D, black arrows) and left ventricular 274 
inferolateral wall (D, white pentagon). 275 
 276 
Figure 2. Abnormal right ventricular features mimicking ARVC. 277 
Four chamber long axis cine view showing a distorted right ventricle (A) in a patient with pectus excavatum (B, 278 
solid white arrow). Four chamber long axis cine view showing heart displacement towards the left with cardiac 279 
apex pointing posteriorly (C, white arrow-head) and evidence of lung interposition between the aorta and the 280 
pulmonary artery (D, white arrow) in a patient with partial congenital absence of the pericardium.  281 
 282 
Figure 3. Pre-tricuspid shunting mimicking ARVC  283 
Four chamber long axis view showing dilated right ventricle (A) in a patient with evidence of atrial septal defect 284 
and left to right shunting on the short axis view (B, solid arrow). Four chamber long axis cine view showing 285 
dilated right ventricle with septal flattening, in keeping with right ventricular overload (C) in a patient with left 286 
upper pulmonary vein (D, white arrow) draining into the brachiocephalic trunk. 287 
